StockData
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp (BGLC) income statement

BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 19, 2026Score 4/30
$0.68+0.00 (0.00%)

Close on Nov 20, 2026Market cap $1.99MP/E –Yield –

See a number that looks wrong?